A federal district judge in Baltimore, Md., yesterday stayed the brand drug industry’s lawsuit challenging the December 2020 340B program administrative dispute resolution final rule.
Lawyers for Pharmaceutical Research and Manufacturers of America and U.S. Health and Human Services Secretary Xavier Becerra on Friday jointly asked U.S. District Judge Deborah Boardman to pause PhRMA’s suit. PhRMA says the 340B ADR rule is unconstitutional and illegal. The U.S. Health Resources and Services Administration in November published a proposed rule to make the 340B ADR process, in its words, more accessible and less trial-like. Comments were due Jan. 30.
A federal district judge in Baltimore, Md., yesterday stayed the brand drug industry’s lawsuit challenging the December 2020 340B program administrative dispute resolution final rule.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
